Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Dreamscape Media Partners with Turner Publishing for Release of DO NO HARM: THE OPIOID EPIDEMIC, a Harrowing Multimedia Series on America's Rampant Opioid Crisis

New audiobook, documentary film and university lecture deliver poignant commentary and expert investigation on public health epidemic

Dreamscape logo (PRNewsfoto/Dreamscape Media)

News provided by

Dreamscape Media

Feb 24, 2020, 15:55 ET

Share this article

Share toX

Share this article

Share toX

HOLLAND, Ohio, Feb. 24, 2020 /PRNewswire/ -- Dreamscape Media, the publishing and entertainment arm of Midwest Tape, today announced the release of DO NO HARM: THE OPIOID EPIDEMIC, a multimedia educational series that chronicles the progression of what experts deem the "worst man-made public health epidemic in American history." Documented through the poignant stories of the individuals and communities most impacted by the crisis, DO NO HARM: The OPIOID EPIDEMIC investigates the epidemic as it unfolded, and the grassroots movement to combat it. The content series includes a documentary, a new audiobook produced by Dreamscape Media and a taped lecture by Dr. Andrew Kolodny, one of the nation's foremost experts on drug addiction. Public library patrons with a valid library card can access each title in the series through hoopla digital, Midwest Tape's mobile and online service for public libraries. The audiobook will also be available for purchase through Amazon, Audible and Apple.

Continue Reading
Dreamscape Media partners with Turner Publishing for audiobook release of DO NO HARM: THE OPIOID EPIDEMIC, one of three titles in multimedia series. DO NO HARM: THE OPIOID EPIDEMIC audiobook now available on hoopla digital, Amazon, Audible and Apple.
Dreamscape Media partners with Turner Publishing for audiobook release of DO NO HARM: THE OPIOID EPIDEMIC, one of three titles in multimedia series. DO NO HARM: THE OPIOID EPIDEMIC audiobook now available on hoopla digital, Amazon, Audible and Apple.
Dreamscape Media release of educational series on opioid crisis includes, “The Prescription Opioid and Heroin Crisis: An Epidemic Of Addiction” a taped lecture from addiction expert Dr. Andrew Kolodny. Public library patrons with a valid library card can access each title in the content series through hoopla digital.
Dreamscape Media release of educational series on opioid crisis includes, “The Prescription Opioid and Heroin Crisis: An Epidemic Of Addiction” a taped lecture from addiction expert Dr. Andrew Kolodny. Public library patrons with a valid library card can access each title in the content series through hoopla digital.
DO NO HARM: THE OPIOID EPIDEMIC documentary investigates America's opioid epidemic through harrowing stories of the individuals and communities most impacted by the crisis. Film from Harry Wiland now available to patrons with a valid library card through hoopla digital.
DO NO HARM: THE OPIOID EPIDEMIC documentary investigates America's opioid epidemic through harrowing stories of the individuals and communities most impacted by the crisis. Film from Harry Wiland now available to patrons with a valid library card through hoopla digital.

"Every 11 minutes, someone in the U.S. dies from an opioid overdose1. The statistics are staggering – and they're causing devastation within our families, our communities, and every sector of our economy," said Harry Wiland, director of the film, DO NO HARM: THE OPIOID EPIDEMIC and author of its accompanying book of the same name. "My intent with DO NO HARM: THE OPIOID EPIDEMIC was to document how this crisis ballooned into an epidemic, to demand accountability and to shed light on the Heroes within the movement and the physicians who are looking for solutions to this worst manmade epidemic."

Wiland's feature documentary (run time: 1 hr:30 min), produced by Media Policy Center, explores the roots of the epidemic from the perspectives of those most devastated by its progression. Filmed in the opioid epidemic ground zeros of Seattle, Kentucky and New Hampshire, the documentary features poignant stories from those hit hardest by prescription opioid addiction and overdose death. The documentary is narrated by Golden Globe®-winning actor Ed Harris.

The book from Turner Publishing, a follow-up to the film, pairs Wiland with researcher and journalist Peter Segall, and Executive Director of Physicians for Responsible Opioid Prescribing, Dr. Andrew Kolodny, for an examination of how the crisis quietly, and devastatingly, reached epidemic levels. The audiobook is narrated by Adam Barr.

"This was an important acquisition for us, because we know how many lives the opioid crisis has touched," said Turner Publishing Executive Editor Stephanie Beard. "This book will be an essential part of the continued efforts by policy makers and health professionals to educate the public about the dangers of opioid abuse."

"No community is immune to the devastation of the opioid crisis, and so many will suffer in silence," said Dreamscape Media Publisher Tammy Faxel, "Wiland and the team at Turner Publishing are giving these communities a voice. Dreamscape is committed to elevating stories that can inspire action, and collaborating with talented storytellers, like Wiland, to raise these critical issues. We also want to ensure this work is accessible to a wider audience, by opening its distribution to both library and retail audiences. Through hoopla digital, each title in the DO NO HARM: THE OPIOID EPIDEMIC content series is available to anyone with a valid library card." 

As part of the series, Dreamscape Media has also released "The Prescription Opioid and Heroin Crisis: An Epidemic of Addiction," Dr. Kolodny's lecture from the 2018 Prescription Drug Abuse & Heroin Summit. In his lecture, Dr. Kolodny, featured prominently in the film and the book, addresses the steps of action the U.S. must take to save its citizens from succumbing to the effects of addiction.

"I believe that education is the key to fighting this epidemic. Through raw storytelling we can quite literally save lives, and save our communities," added Wiland. "Dreamscape Media created a platform for these crucial stories to be heard."

About Dreamscape Media:

Dreamscape Media (dreamscapeab.com) is a privately held media development firm focusing on audio and video production, distribution and licensing in the publishing and video markets, with an emphasis on the library/educational market. The company produces fiction and non‐fiction audiobooks, book-based children's read‐along video programs, and offers video distribution services. Titles are available to both library and retail channels in physical and digital formats. Dreamscape has received hundreds of awards and accolades for high quality audio productions, including a 2018 Audie Award, the highest award for audiobook production. Dreamscape is the publishing arm of Midwest Tape – a trusted partner to public libraries for nearly 30 years. To learn more, visit Dreamscapeab.com and connect with Dreamscape on Facebook, Twitter and Instagram.

About Turner Publishing Company
Headquartered in Nashville, TN & operating since 1984, Turner currently publishes more than 5,000 titles. Turner has a broad array of titles in fiction & non-fiction, including business, young adult, history, romance, mystery, cookbooks, health & wellness, animals, design, and more. Turner continues to expand their titles by acquiring innovative content from existing and debut authors worldwide. Turner books are currently being sold in over 55 countries & continuing to grow.

1 ([1] Hedegaard H, Miniño AM, Warner M. Drug overdose deaths in the United States, 1999–2017. NCHS Data Brief, no 329. Hyattsville, MD: National Center for Health Statistics. 2018.)

SOURCE Dreamscape Media

Related Links

https://www.dreamscapeab.com

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.